Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Jeffrey Fadrowski, Johns Hopkins University Identifier:
First received: December 9, 2008
Last updated: August 31, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)